Views: 409 | Downloads:
6
| Responses: 0
XML | Respond to this article | Alert & updates | Request permissions | Email to a friend |
Special ArticleOpen Access
Advances in Alternative Pharmacotherapy of ADHD
Several alternatives to psychostimulants have been developed and expanded the variability of the treatment of ADHD. Clonidine is a good option for managing core behavioral symptoms, especially hyperactivity and impulsivity. Bupropion and venlafaxine seem potentially promising. Significant new options include norepinephrine reuptake inhibitors, such as atomoxetine, and possibly selective dopamine agonists. Central anticholinesterases, such as donepezil, may improve core ADHD symptoms.
Keywords: ADHD, Pharmacotherapy
Download:
PDF